Stockscreener 앱 받기
12.94
4.46%
-0.575
Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스
Edgewise Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock with $46 price target - Investing.com Canada
Edgewise Therapeutics' Accelerating Clinical Pipeline: A Catalyst for Valuation Re-rating in 2025? - AInvest
Edgewise Therapeutics shares surge as Q2 loss narrows, beats estimates By Investing.com - Investing.com South Africa
Edgewise Therapeutics: Pioneering Muscle Disease Innovation with Strong Q2 Results and Promising Late-Stage Pipeline - AInvest
Edgewise Therapeutics, Inc. SEC 10-Q Report - TradingView
Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Applying Wyckoff theory to Edgewise Therapeutics Inc. stockLow Risk Trade Timing with Analysis Metrics - Newser
Edgewise Therapeutics Inc. stock trendline breakdownHigh Yield Signals with Entry Timing - Newser
Edgewise Therapeutics (EWTX) to Release Earnings on Thursday - MarketBeat
TD Asset Management Inc Buys New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Grants $1.2M Stock Options Package: New Hires Get Equity at $14.26 Per Share - Stock Titan
How Edgewise Therapeutics Inc. stock performs during market volatilityIntraday Strategy with Real Time Monitoring - Newser
Is Edgewise Therapeutics Inc. stock poised for growthSector Rotation Outlook With Historical Summary - Newser
Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9%Here's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Edgewise EWTX 2025Q2 Earnings Preview Upside Potential Amid Clinical Trial Progress - AInvest
Pomerantz LLP investigates Edgewise Therapeutics over potential securities fraud claims. - AInvest
Quantitative breakdown of Edgewise Therapeutics Inc. recent moveMomentum Trading Guide with Safety Limits - Newser
Visualizing Edgewise Therapeutics Inc. stock with heatmapsDaily Breakout List with Smart Filters - Newser
Can Edgewise Therapeutics Inc. Bounce Back From Weekly LowReversal Alert Based on RSI Indicator Confirmed - metal.it
How Interest Rate Changes Impact Edgewise Therapeutics Inc. Stock PerformanceBuy Strategy with Smart Exit Timing - Newser
What is the risk reward ratio of investing in Edgewise Therapeutics Inc. stockGet timely alerts on top-performing stocks - Jammu Links News
What analysts say about Edgewise Therapeutics Inc. stockInvest confidently with real-time market updates - Jammu Links News
Is Edgewise Therapeutics Inc. stock overvalued or undervaluedFree Consultation - Jammu Links News
Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.3% HigherHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Edgewise Therapeutics, Inc. (EWTX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
What drives Edgewise Therapeutics Inc. stock priceBuild wealth steadily with expert advice - Jammu Links News
Does Edgewise Therapeutics Inc. stock perform well during market downturnsUnlock your portfolio’s full growth potential - Jammu Links News
What catalysts could drive Edgewise Therapeutics Inc. stock higher in 2025Unlock exclusive trading tools and resources - Jammu Links News
Does Edgewise Therapeutics Inc. qualify in momentum factor screeningHigh Probability Trade Outcome Prediction - Newser
What makes Edgewise Therapeutics Inc. stock price move sharplyFree Daily Stock Market Swing Alerts - newser.com
What is the dividend policy of Edgewise Therapeutics Inc. stockAchieve consistent high returns with low risk - Jammu Links News
37,591 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Skandinaviska Enskilda Banken AB publ - MarketBeat
How many analysts rate Edgewise Therapeutics Inc. as a “Buy”Stay ahead with daily expert stock picks - Jammu Links News
Is it the right time to buy Edgewise Therapeutics Inc. stockGain insights from top financial experts - Jammu Links News
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Edgewise Therapeutics Inc. Stock a Good Fit for Conservative InvestorsTrade Plan With Low Risk High Return - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Edgewise Therapeutics, Inc. (EWTX) And Encourages Shareholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - FinancialContent
Raymond James Initiates Strong Buy on Edgewise Therapeutics (EWTX) with $46 PT, Cites EDG-7500 Potential for HCM - Insider Monkey
Edgewise Therapeutics Initiates Coverage with Strong Buy Rating - AInvest
Bronstein, Gewirtz & Grossman, LLC Encourages Edgewise Therapeutics, Inc. (EWTX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - MarketScreener
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by Raymond James Financial - MarketBeat
Heatmap analysis for Edgewise Therapeutics Inc. and competitorsSmart Stock Forecast Using AI Algorithms - Newser
Published on: 2025-07-31 00:37:16 - Newser
How sentiment analysis helps forecast Edgewise Therapeutics Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Edgewise Therapeutics shares fall 1.62% after-hours despite Raymond James initiating a Strong Buy rating. - AInvest
0.14%
0.27%
자본화:
|
볼륨(24시간):